T&L Co., Ltd.

Equities

A340570

KR7340570001

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E. Other stock markets 03:30:00 31/05/2024 am IST			5-day change	1st Jan Change
66,000 ^KRW	+6.11%		+4.76%	+65.00%

2023	Tranche Update on T&L Co., Ltd.'s Equity Buyback Plan announced on June 15, 2022.	CI
2023	Tranche Update on T&L Co., Ltd.'s Equity Buyback Plan announced on June 15, 2022.	CI

Tranche Update on T&L Co., Ltd.'s Equity Buyback Plan announced on June 15, 2022.

June 13, 2023 at 02:15 pm IST

From October 1, 2022 to December 31, 2022, the company has repurchased 42,231 shares, representing 0.52% for KRW 1,449.33 million. With this, the company has completed the repurchase of 55,988 shares, representing 0.69% for KRW 1,878.86 million under the buyback announced on June 15, 2022.

Latest news about T&L Co., Ltd.

Tranche Update on T&L Co., Ltd.'s Equity Buyback Plan announced on June 15, 2022.	13/23/13	CI
Tranche Update on T&L Co., Ltd.'s Equity Buyback Plan announced on June 15, 2022.	13/23/13	CI
Tranche Update on T&L Co., Ltd.'s Equity Buyback Plan announced on June 15, 2022.	13/23/13	CI
Tranche Update on T&L Co., Ltd.'s Equity Buyback Plan announced on June 15, 2022.	13/23/13	CI
Tranche Update on T&L Co., Ltd.'s Equity Buyback Plan announced on June 15, 2022.	13/23/13	CI
T&L Co., Ltd.'s Equity Buyback announced on June 15, 2022, has expired with 55,989 shares, representing 0.69% for KRW 1,878.89 million.	13/23/13	CI
T&L Co., Ltd.'s Equity Buyback Plan Extended till June 13, 2023.	13/22/13	CI
T&L Co., Ltd. announces an Equity Buyback for KRW 10,000 million worth of its shares.	15/22/15	CI
T&L Co., Ltd. authorizes a Buyback Plan.	15/22/15	CI
T&L Co., Ltd.(KOSDAQ:A340570) added to S&P Global BMI Index	20/21/20	CI
1,388,000 Common Stock of T&L Co., Ltd. are subject to a Lock-Up Agreement Ending on 20-JUN-2021.	20/21/20	CI
24,000 Common Stock of T&L Co., Ltd. are subject to a Lock-Up Agreement Ending on 20-MAR-2021.	20/21/20	CI
T&L Co., Ltd. has completed an IPO in the amount of KRW 28.8 billion.	16/20/16	CI
T&L Co., Ltd. has filed an IPO.	28/20/28	CI

Chart T&L Co., Ltd.

Duration

Period

More charts

Company Profile

T&L Co Ltd is a Korea-based company engaged in the manufacture and sale of wound treatment materials. The Company's main products include wound treatment materials, orthopedic fixing materials, structural adhesives, and water repellents. The wound treatment materials include products such as hydrocolloids, foams, and hydrogels as wetting dressing agents necessary for wound healing. The orthopedic fixture materials include medical devices used for the treatment and correction of fractures such as casts and splints. The company sells its products in domestic and overseas markets such as the United States, Germany, China, and Dubai.

Sector

Medical Equipment, Supplies & Distribution

Calendar

09/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for T&L Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

66,000 KRW

Average target price

71,500 KRW

Spread / Average Target

+8.33%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
T&L CO., LTD.	+65.00%	39Cr
ABBOTT LABORATORIES	-7.16%	18TCr
BECTON, DICKINSON AND COMPANY	-4.86%	6.7TCr
DEXCOM, INC.	-4.28%	4.72TCr
CENCORA, INC.	+10.32%	4.46TCr
HOYA CORPORATION	+8.14%	4.25TCr
METTLER-TOLEDO INTERNATIONAL, INC.	+15.76%	3TCr
TERUMO CORPORATION	+15.53%	2.52TCr
WEST PHARMACEUTICAL SERVICES, INC.	-5.88%	2.41TCr
ZIMMER BIOMET HOLDINGS, INC.	-5.38%	2.37TCr

Other Medical Equipment, Supplies & Distribution